Kasvu Therapeutics
Kasvu Therapeutics develops small-molecule treatments intended to stimulate neuroplasticity without the hallucinogenic effects associated with psychedelic drugs.
€30MSeries A
ParticipantSI
Stephen Industries
Activity from announced rounds
All recorded activity
Stephen Industries is the corporate investor named by AlixLabs and in Kasvu financing coverage.
Recorded funding activity
AlixLabs develops semiconductor etching processes. Kasvu develops non-hallucinogenic neuroplasticity treatments, while Anferra recycles steel waste. The records retain distinct technologies and keep unpublished participation in draft.
- Rounds participated in
- 3
- Confirmed lead rounds
- 0 1 roles undisclosed
- New companies
- 3 First participation on record · 0 follow-on
- Funding in participating rounds
- $51.8M 2 disclosed · full round size, not this investor’s share
By stage
By primary sector
By country
Rounds
3 in all activityAnferra AB
Anferra develops a recycling process that turns steel grinding waste into iron chloride for water treatment, hydrogen and recoverable alloy materials.
UndisclosedStrategic
Role not disclosedAlixLabs
AlixLabs develops atomic-layer etching processes and equipment for semiconductor manufacturers making smaller, more densely packed chip features.
€15MSeries A
Participant